-
公开(公告)号:US11807683B2
公开(公告)日:2023-11-07
申请号:US17046388
申请日:2019-04-11
发明人: Xiaoqiang Kang , Shoupeng Lai , Xiao Huang
IPC分类号: A61K39/395 , C07K16/28 , A61K38/20 , A61K39/00
CPC分类号: C07K16/2803 , A61K39/39541 , A61K38/2013 , A61K2039/505 , C07K16/2818 , C07K16/2827 , C07K16/2878 , C07K2317/24 , C07K2317/76
摘要: The present invention provides an isolated monoclonal antibody that specifically binds human TIM-3. The present invention further provides a pharmaceutical composition comprising the antibody, as well as uses thereof.
-
公开(公告)号:US11136394B2
公开(公告)日:2021-10-05
申请号:US16414724
申请日:2019-05-16
发明人: Xiaoqiang Kang , Shoupeng Lai , Xiao Huang
摘要: The present invention provides an isolated monoclonal antibody that specifically binds human PD-1. A nucleic acid molecule encoding the antibody, an expression vector, a host cell and a method for expressing the antibody are also provided. The present invention further provides an immunoconjugate, a bispecific molecule and a pharmaceutical composition comprising the antibody, as well as a diagnostic and treatment method using an anti-PD-1 antibody of the invention.
-
公开(公告)号:US11466086B2
公开(公告)日:2022-10-11
申请号:US17038669
申请日:2020-09-30
发明人: Xiaoqiang Kang , Xiao Huang , Jianming Sun
摘要: Disclosed is an isolated monoclonal antibody that specifically binds human 4-1BB, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody, an expression vector, a host cell and a method for expressing the antibody are also provided. The present disclosure further provides a bispecific molecule, and a pharmaceutical composition comprising the antibody or the bispecific molecule, as well as a treatment method using an anti-4-1BB antibody of the disclosure.
-
公开(公告)号:US20210115142A1
公开(公告)日:2021-04-22
申请号:US17075212
申请日:2020-10-20
发明人: Xiaoqiang Kang , Xiao Huang
摘要: A recombinant fusion protein comprising 1) TGFβR2, or a fragment thereof, capable of binding to TGFβ, and 2) an antibody, or an antigen-binding fragment thereof, that binds to PD-1. Also disclosed are a polynucleotide encoding the recombinant fusion protein, an expression vector containing the polynucleotide, a method for producing the recombinant protein and a method for treating a disease caused by over expression of TGFβ and/or PD-1 using the recombinant protein.
-
公开(公告)号:US11912777B2
公开(公告)日:2024-02-27
申请号:US18064061
申请日:2022-12-09
发明人: Xiaoqiang Kang , Shoupeng Lai , Xiao Huang , Huan Lin , Yujia Dang
CPC分类号: C07K16/2878 , A61P1/00 , A61P35/00 , C07K16/2818 , G01N33/6863 , A61K2039/505 , A61K2039/507 , C07K2317/24 , C07K2317/31 , C07K2317/34 , C07K2317/732 , C07K2317/74 , C07K2317/76 , C07K2317/92 , G01N2333/70578
摘要: The present invention relates to a novel antibody and antibody fragment that specifically binds to TNFR2 and to a composition comprising said antibody or antibody fragment. In addition, the present invention relates to a nucleic acid encoding the antibody or an antibody fragment thereof and a host cell comprising the same, and to a related use thereof. Besides, the present invention relates to the use of the antibody and antibody fragment for treatment and diagnosis.
-
公开(公告)号:US20240025967A1
公开(公告)日:2024-01-25
申请号:US18472656
申请日:2023-09-22
发明人: Xiaoqiang Kang , Xiao Huang
IPC分类号: C07K14/705 , C07K16/28 , C07K14/71 , A61P35/00 , C12N5/10 , C12N15/63 , A61K31/713
CPC分类号: C07K14/70596 , C07K16/2818 , C07K14/71 , A61P35/00 , C12N5/10 , C12N15/63 , A61K31/713 , C07K2319/33 , C07K2317/94 , C07K2317/565 , C07K2317/92 , C07K2317/76 , A61K2039/505
摘要: A recombinant fusion protein comprising 1) TGFβR2, or a fragment thereof, capable of binding to TGFβ, and 2) an antibody, or an antigen-binding fragment thereof, that binds to PD-1. Also disclosed are a polynucleotide encoding the recombinant fusion protein, an expression vector containing the polynucleotide, a method for producing the recombinant protein and a method for treating a disease caused by over expression of TGFβ and/or PD-1 using the recombinant protein.
-
公开(公告)号:US11802145B2
公开(公告)日:2023-10-31
申请号:US17075212
申请日:2020-10-20
发明人: Xiaoqiang Kang , Xiao Huang
IPC分类号: C07K14/705 , C07K16/28 , C07K14/71 , A61P35/00 , C12N5/10 , C12N15/63 , A61K31/713 , A61K39/00
CPC分类号: C07K14/70596 , A61K31/713 , A61P35/00 , C07K14/71 , C07K16/2818 , C12N5/10 , C12N15/63 , A61K2039/505 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C07K2319/32 , C07K2319/33
摘要: A recombinant fusion protein comprising 1) TGFβR2, or a fragment thereof, capable of binding to TGFβ, and 2) an antibody, or an antigen-binding fragment thereof, that binds to PD-1. Also disclosed are a polynucleotide encoding the recombinant fusion protein, an expression vector containing the polynucleotide, a method for producing the recombinant protein and a method for treating a disease caused by over expression of TGFβ and/or PD-1 using the recombinant protein.
-
公开(公告)号:US20230212302A1
公开(公告)日:2023-07-06
申请号:US18064061
申请日:2022-12-09
发明人: Xiaoqiang Kang , Shoupeng Lai , Xiao Huang , Huan Lin , Yujia Dang
CPC分类号: C07K16/2878 , A61P1/00 , A61P35/00 , C07K16/2818 , G01N33/6863 , A61K2039/505 , C07K2317/24 , C07K2317/31 , C07K2317/74 , C07K2317/76 , C07K2317/92
摘要: The present invention relates to a novel antibody and antibody fragment that specifically binds to TNFR2 and to a composition comprising said antibody or antibody fragment. In addition, the present invention relates to a nucleic acid encoding the antibody or an antibody fragment thereof and a host cell comprising the same, and to a related use thereof. Besides, the present invention relates to the use of the antibody and antibody fragment for treatment and diagnosis.
-
公开(公告)号:US20230192862A1
公开(公告)日:2023-06-22
申请号:US18045133
申请日:2022-10-07
发明人: Xiaoqiang Kang , Xiao Huang , Jianming Sun
CPC分类号: C07K16/2827 , C07K16/30 , A61P35/00 , C07K2317/24 , C07K2317/51 , C07K2317/565 , C07K2317/622 , C07K2317/54 , C07K2317/31
摘要: Disclosed is an isolated monoclonal antibody that specifically binds human 4-1BB, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody, an expression vector, a host cell and a method for expressing the antibody are also provided. The present disclosure further provides a bispecific molecule, and a pharmaceutical composition comprising the antibody or the bispecific molecule, as well as a treatment method using an anti-4-1BB antibody of the disclosure.
-
公开(公告)号:US20210221885A1
公开(公告)日:2021-07-22
申请号:US17046388
申请日:2019-04-11
发明人: Xiaoqiang Kang , Shoupeng Lai , Xiao Huang
IPC分类号: C07K16/28 , A61K39/395 , A61K45/06 , A61K38/20
摘要: The present invention provides an isolated monoclonal antibody that specifically binds human TIM-3. The present invention further provides a pharmaceutical composition comprising the antibody, as well as uses thereof.
-
-
-
-
-
-
-
-
-